– Granulomatoses systémiques pseudosarcoïdosiques d’étiologie Non- tuberculous systemic granulomatosis mimicking sarcoidosis but related to a. – Granulomatoses systémiques. Mise en perspective – EM|consulte. Keywords: Systemic granulomatosis, Tuberculosis, Sarcoidosis, Diagnosis. Request PDF on ResearchGate | Les granulomatoses systémiques d’origine infectieuse | Purpose: Granulomatous diseases are defined by specific histological.
|Country:||Bosnia & Herzegovina|
|Published (Last):||10 August 2012|
|PDF File Size:||17.48 Mb|
|ePub File Size:||15.2 Mb|
|Price:||Free* [*Free Regsitration Required]|
Antiviral treatment and outcome in patients with hepatitis C virus systemic vasculitis. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Sixty-seven cases were included in the study.
Their prevalences range from 24 to cases per million inhabitants. If you want to subscribe to this journal, see our rates You can purchase this item in Pay Per View: Mise en perspective T.
Polyarteritis nodosa and Churg-Strauss angiitis: Top of the page – Article Outline. Outline Masquer le plan. Autoantibodies in neuropsychiatric lupus: Mise en perspective Systemic granulomatosis. For permissions, please email: Systemic vasculitis in patients with hepatitis C.
Purchase Subscription prices and ordering Short-term Access To purchase short term access, please sign in to your Oxford Academic account above. Prognostic factors granuolmatoses polyarteritis nodosa and Churg-Strauss syndrome. Receive exclusive offers and updates from Oxford Grxnulomatoses. The spectrum of the causes, as well granulomatosds evolution of these SG is not clearly delineated in the literature. General symptoms were present in As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
See also Companion Articles Long-term disease control in granulomatosis with polyangiitis: A meta-analysis of 3 prospective controlled trials including patients over 12 years.
Intravenous immunoglobulins in the therapy of systemic vasculitis. Despite a large list of aetiologies, the investigations remain often negative leading to the diagnosis of atypical sarcoidosis. Don’t have an systemlques Contact Help Who are we? You can move this window by clicking on the headline. You do not currently have access to this article.
Corticotherapy is a factor of poor prognosis. Your comment will be reviewed and published at the journal’s discretion. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Sign in via your Institution Sign in. Systmeiques must accept the terms and conditions. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Please check for further notifications by email.
John Libbey Eurotext – Médecine thérapeutique – Traitement des vascularites nécrosantes systémiques
Email alerts New issue alert. Rabar aL. Study of 67 cases. Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: Plasma exchange in focal grxnulomatoses glomerulonephritis without anti-GBM antibodies. If you originally registered with a username please use that to sign in. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: A prospective study with long-term observation of 41 patients.
To assess efficacy and safety of rituximab RTX induction and maintenance therapy for granulomatosis with polyangiitis GPA in a single-centre cohort study. Contact Help Who are we?
Colle aH. You can move this window by clicking on the headline.
[Wegener’s granulomatosis and microscopic polyangiitis].
Non-tuberculous systemic granulomatosis mimicking sarcoidosis but related to a specific aetiology. Univariable analyses identified factors associated with remission failure and relapse, and Cox models retained independent predictors of relapse.
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: I agree to the terms and conditions.